Do you want to read an article? Please log in or register.
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
Tuberculosis
RECOMMENDED
Related content
RECOMMENDED
Respiratory Tract Infection
Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Glob Health.
Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, Sawadogo-Lewis T, Walker N
doi: 10.1016/S2214-109X(20)30229-1.
RECOMMENDED
Tuberculosis
The impact of HIV infection on tuberculosis transmission in a country with low tuberculosis incidence: a national retrospective study using molecular epidemiology
★ 2
Recommended by
Dr Martin Frey, Faculty Member
BMC Med
Winter JR, Smith CJ, Davidson JA, Lalor MK, Delpech V, Abubakar I, Stagg HR
doi: 10.1186/s12916-020-01849-7
RECOMMENDED
Respiratory Tract Infection
Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1016/S2468-2667(20)30082-7.
RECOMMENDED
Pulmonary Fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L
doi: 10.1016/j.jcf.2020.07.022.
RECOMMENDED
Tuberculosis
Impact of COVID-19 pandemic on tuberculosis laboratory services in Europe
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Nikolayevskyy V, Holicka Y, van Soolingen D, van der Werf MJ, Ködmön C, Surkova E, Hillemann D, Groenheit R, Cirillo D, ERLTB-Net-2 study participants.
doi: 10.1183/13993003.03890-2020.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Lung Cancer
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Oncol.
Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini AC, Bria E, Brighenti M, Cadranel J, De Toma A, Chini C, Cortellini A, Felip E, Finocchiaro G, Garrido P, Genova C, Giusti R, Gregorc V, Grossi F, Grosso F, Intagliata S, La Verde N, Liu SV, Mazieres J, Mercadante E, Michielin O, Minuti G, Moro-Sibilot D, Pasello G, Passaro A, Scotti V, Solli P, Stroppa E, Tiseo M, Viscardi G, Voltolini L, Wu YL, Zai S, Pancaldi V, Dingemans AM, Van Meerbeeck J, Barlesi F, Wakelee H, Peters S, Horn L, TERAVOLT investigators.
doi: 10.1016/S1470-2045(20)30314-4.
Respiratory Tract Infection
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Lancet
Vasileiou E, Simpson CR, Shi T, Kerr S, Agrawal U, Akbari A, Bedston S, Beggs J, Bradley D, Chuter A, de Lusignan S, Docherty AB, Ford D, Hobbs FR, Joy M, Katikireddi SV, Marple J, McCowan C, McGagh D, McMenamin J, Moore E, Murray JL, Pan J, Ritchie L, Shah SA, Stock S, Torabi F, Tsang RS, Wood R, Woolhouse M, Robertson C, Sheikh A
doi: 10.1016/S0140-6736(21)00677-2
RECOMMENDED
Tuberculosis
Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for Mycobacterial Infections (ESGMYC)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Min Ong CW, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Choon Heng BH, Ippolito G, Jankovic M, Kim HY, Klintz SR, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini M, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D
doi: 10.1183/13993003.01727-2020.
RECOMMENDED
Respiratory Tract Infection
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Giannouchos TV, Sussman RA, Mier JM, Poulas K, Farsalinos K
doi: 10.1183/13993003.02144-2020.